honeybee

Researchers


Do you have Type 2 Diabetes?

Mount Sinai Hospital, Leadership Sinai Centre for Diabetes


Type 2 Diabetes Mellitus (T2DM) is a chronic and progressive condition characterised by worsening glucose control over time. This process is driven by deterioration of the cells in the body that make insulin, the pancreatic beta cells. Current therapies for early type 2 diabetes can improve glucose control but they do not protect the pancreatic beta cells from deterioration. PREVAIL is a government funded clinical trial for people with early T2DM. Our aim is to investigate therapies to protect the pancreatic beta cells and slow the progression of diabetes. We are currently inviting participants to join our study.

Your Impact

Mount Sinai Hospital is researching how to protect the cells in the body that produce insulin in order to slow the progression of diabetes and ideally reverse it. We are inviting participants to join our study.

Eligibility Criteria

All genders

30 to 80 years old

Have had diabetes for 0-7 years, and take 0-2 oral medications for diabetes

Study Tasks

provide blood sample
complete questionnaires
provide blood pressure and body measurements
participate in study treatment

Ethics

This study has been approved by Mount Sinai's Research Ethics Board (MSH REB# #14-0128-A)

Keywords

type 2 diabetes
diabetes mellitus
metformin
insulin
carbohydrate
Activity and Time

Health and Wellness

Clinical Trial

Weekdays

3 hour(s) per session

4 session(s)

Compensation

Do this one out of kindness

Reimbursement

parking and/or local public transportation covered, and study supplies provided

Study Address

60 Murray Street Toronto, Ontario, Canada, M5T 3L9

Posting date: May 22, 2019